| 摘要: |
| 近年来，2型糖尿病（diabetes mellitus type 2，T2DM）和心力衰竭（heart failure，HF）的发病率呈明显上升趋势。两病常共存，与单一慢性病患者相比，共病患者存在较差的生活质量以及不良预后的问题。因此，对患单一疾病的患者进行早期识别和预防显得尤为关键。本文主要从疾病危险因素、病理生理学机制及药物治疗等方面阐述HF和T2DM的共病的研究进展，以帮助临床医生早期识别合并高风险的单病患者，并实施有效的药物干预来改善疾病预后。 |
| 关键词: 2型糖尿病 心力衰竭 共病 药物 |
| DOI： |
| 分类号: |
| 基金项目:武汉科技大学，职业危害识别与控制湖北省重点实验室开放基金（编号：OHIC2022G02） |
|
| Research progress on the prevention and treatment of co-morbidities of type 2 diabetes and heart failure |
|
张红
|
|
Tianyou Hospital to Wuhan University Of Science and Technology
|
| Abstract: |
| In recent years, the prevalence of type 2 diabetes mellitus (T2DM) and heart failure (HF) has been increasing significantly. The two diseases often coexist, and patients with co-morbidities suffer from poorer quality of life as well as a poorer prognosis than patients with a single chronic disease. Therefore, early identification and prevention of patients with either of these conditions are crucial. This article mainly elaborates on the research progress of comorbidity of HF and T2DM from the risk factors, pathophysiological mechanisms, and pharmacological treatment, to help clinical physicians identify high-risk single-disease patients early and implement effective drug interventions to improve disease prognosis. |
| Key words: Type 2 diabetes mellitus Heart failure Comorbidity Drugs |
